Clinical trial
A Phase 1 Clinical Study to Investigate the Pharmacokinetics and…
NCT02470286 · Samjin Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT02470286 |
|---|---|
| Title | A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers |
| Official title | A Phase1, Double-blind, Randomized, Placebo-control, Single Center, Single Dose Administration, Dose Escalation Study to Investigate the Pharmacokinetics, Safety and Tolerability of SA001 in Healthy Male Volunteers. |
| Lead sponsor | Samjin Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | SA001 60mg or Placebo, SA001 120mg or Placebo, SA001 180mg or Placebo, SA001 240mg or Placebo, SA001 300mg or Placebo |
| Enrollment | 40 |
| Start date | Jun 29, 2015 |
| Primary completion | Sep 18, 2015 |
| Completion | Sep 30, 2015 |
| First posted | Jun 12, 2015 |
| Last update posted | Mar 24, 2022 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: